The Inflation Reduction Act promises to reduce drug prices. But the law is more financial gamesmanship than true patient advocacy,...
Read moreThe DOJ has been actively supporting abortion access. This may appear good, but it becomes concerning when we define medical...
Read moreWe present a model to discern probable cause out of clinical data. We seek collaboration opportunities with interested health insurers...
Read moreWhen charges are hurled against a physician, all of medicine feels the effects. It cultivates a culture of fear that...
Read moreThe FDA makes inconsistent policy decisions with little regard to data. It feigns incompetence to cover for its conflicting incentives.
Read moreLegal encroachment into medicine creates an artificial conformity. It has led to landmark legal settlements, but poor quality of care.
Read moreWe often make false equivalencies when debating gun policy. But one thing is clear: there is an inverse relationship between...
Read moreThe recent ruling by the Supreme Court sent the country into a tailspin of outrage. However, the problem is not...
Read moreThe Supreme Court clarified the matter of good faith in opioid cases. The ruling will improve the patient-physician relationship and...
Read moreThe ONDCP announced an initiative aimed at reducing overdose deaths. But by limiting all of addiction into a metric, we...
Read moreA call for an independent investigation into the origins of COVID-19 renews interest in the virus's mutation patterns. It also...
Read moreMedicine and law have strained their relationship, butting heads on a host of issues of late. The problem lies in...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy